Healthy volunteers help test new drug form
NCT ID NCT07206043
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 30 times
Summary
This study tested a new, stronger version of the drug RPH-104 in 130 healthy adults aged 18-45. The goal was to see how safe it is, how the body processes it, and whether it triggers an immune response. No treatment was given for any disease, so this study helps gather important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Llc "Research Lab"
Moscow, 127521, Russia
Conditions
Explore the condition pages connected to this study.